GLUE

Monte Rosa Therapeutics (GLUE)

About Monte Rosa Therapeutics (GLUE)

Monte Rosa Therapeutics, Inc. operates as a biotechnology company, which engages in the developing of precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.

Details

Daily high
$18.98
Daily low
$17.19
Price at open
--
52 Week High
$18.98
52 Week Low
$3.50
Market cap
1.2B
Dividend yield
0.00%
Volume
191
Avg. volume
900,296
P/E ratio
61.10

Monte Rosa Therapeutics News

Details

Daily high
$18.98
Daily low
$17.19
Price at open
--
52 Week High
$18.98
52 Week Low
$3.50
Market cap
1.2B
Dividend yield
0.00%
Volume
191
Avg. volume
900,296
P/E ratio
61.10